Market: NASD |
Currency: USD
Address: 5375 Medpace Way
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Show more
📈 Medpace Holdings, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$418.40
-
Upside/Downside from Analyst Target:
-10.37%
-
Broker Call:
-3
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
10-25%
-
Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
2025-10-21
-
EPS Estimate:
3.55
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Medpace Holdings, Inc.
Date | Reported EPS |
---|
2025-10-20 (estimated upcoming) | - |
2025-07-21 | 3.1 |
2025-04-21 | 3.67 |
2025-02-10 | 3.68 |
2024-10-21 | 3.01 |
2024-07-22 | 2.76 |
2024-04-22 | 3.22 |
2024-02-12 | 2.48 |
2023-10-23 | 2.24 |
2023-07-24 | 1.95 |
2023-04-24 | 2.28 |
2023-02-13 | 2.14 |
2022-10-24 | 2.07 |
2022-07-25 | 1.48 |
2022-04-25 | 1.71 |
2022-02-14 | 1.36 |
2021-10-25 | 1.32 |
2021-07-26 | 1.09 |
2021-04-26 | 1.18 |
2021-02-15 | 1.4 |
2020-10-26 | 1.14 |
2020-07-27 | 0.68 |
2020-04-28 | 0.8 |
2020-02-24 | 0.85 |
2019-10-28 | 0.71 |
📰 Related News & Research
No related articles found for "medpace holdings".